levomepromazine

Methotrimeprazine is an orally available neuroleptic agent. It is commonly used to relieve nausea and vomiting in palliative care settings. Levomepromazine has antagonist actions at multiple neurotransmitter receptor sites, including cholinergic, dopamine

(±)-Levomepromazine is the Levomepromazine racemate. Levomepromazine is an orally active and typical antipsychotic agent [1].

Levomepromazine HCl is a phenothiazine with pharmacological activity similar to that of both CHLORPROMAZINE and PROMETHAZINE. It has the histamine-antagonist properties of the antihistamines together with CENTRAL NERVOUS SYSTEM effects resembling those of chlorpromazine.

Methotrimeprazine-d6 (Racemic) is a deuterated compound of Methotrimeprazine (Racemic). Methotrimeprazine (Racemic) has a CAS number of 851-68-3.

Levomepromazine Maleate is a Tricyclic antidepressant (TCA), acting as a serotonin–norepinephrine reuptake inhibitor (SNRI) and also having other activities including antihistamine, antiadrenergic, antiserotonergic, anticholinergic, and sodium channel-blocking effects.

Org 31806 is a progestational hormone antagonist.